SCHEMBL18529404

SCHEMBL18529404

N#Cc1c(-n2cccc2)[nH]c2ccccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNMA1 Q12791 2/20 0.43
ALDH1A1 P00352 4/20 0.43
GPR3 P46089 1/20 0.43
HSD17B10 Q99714 1/20 0.43
PDE9A O76083 6/20 0.43
MAPT P10636 2/20 0.43
KDM4E B2RXH2 2/20 0.42
GAA P10253 2/20 0.42
LMNA P02545 1/20 0.42
GLA P06280 1/20 0.42
HPGD P15428 1/20 0.42
HTT P42858 1/20 0.42
ATM Q13315 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
GABRP O00591 1/20 0.41
GABRD O14764 1/20 0.41
GABRA1 P14867 1/20 0.41
GABRB1 P18505 1/20 0.41
GABRG2 P18507 1/20 0.41
GABRB3 P28472 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27910999 0.77 KCNMA1 (0.43) KCNMA1ALDH1A1GPR3HSD17B10PDE9A
SCHEMBL17185603 0.74 PDE9A (0.47) ALDH1A1GPR3HSD17B10PDE9AMAPT
SCHEMBL2464667 0.72 PDE9A (0.49) ALDH1A1GPR3HSD17B10PDE9AMAPT
SCHEMBL3676401 0.72 AHR (0.57) ALDH1A1GPR3HSD17B10PDE9AMAPT
SCHEMBL29635217 0.72 PDE9A (0.49) ALDH1A1GPR3HSD17B10PDE9AMAPT
SCHEMBL5858501 0.71 PLA2G1B (0.59) ALDH1A1GPR3HSD17B10PDE9AMAPT
SCHEMBL15926509 0.71 PDE9A (0.47) ALDH1A1GPR3HSD17B10PDE9AMAPT
SCHEMBL1514832 0.71 PDE9A (0.47) ALDH1A1GPR3HSD17B10PDE9AMAPT
SCHEMBL25926841 0.71 PDE9A (0.47) ALDH1A1GPR3HSD17B10PDE9AMAPT
SCHEMBL25929859 0.71 PDE9A (0.47) ALDH1A1GPR3HSD17B10PDE9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017031276-A1 METHODS OF PROVIDING NEUROPROTECTIVE THERAPY RELATED TO ADMINISTERING AN ESTROGEN RECEPTOR BETA LIGAND THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-02-23 WO disclosed